Clinical Trial Update: Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of IV ETI-204 alone and with ciprofloxacin in healthy adult volunteers (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inhalational Anthrax

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• ETI-204

Snippet

Sponsor: Elusys Therapeutics | Conditions: Inhalational Anthrax | Phase 1 | Status: COMPLETED | Results posted: 2019-04-08